Pharma Foods International Co., Ltd. (TYO:2929)
Japan · Delayed Price · Currency is JPY 691.00
-1.00 (-0.14%)
Sep 14, 2026, 3:30 PM JST
TYO:2929 Cash Flow Statement
Financials in millions JPY. Fiscal year is August - July.
Millions JPY. Fiscal year is Aug - Jul.
Operating Activities
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
Period Ending | Jul '25 Jul 31, 2025 | Jul '24 Jul 31, 2024 | Jul '23 Jul 31, 2023 | Jul '22 Jul 31, 2022 |
Net Income | 2,434 | 5,034 | 3,542 | 1,423 |
Depreciation & Amortization | 785 | 907 | 546 | 520 |
Loss (Gain) From Sale of Assets | - | 101 | - | -77 |
Loss (Gain) From Sale of Investments | 118 | 113 | 50 | 1 |
Loss (Gain) on Equity Investments | 131 | 35 | 82 | -5 |
Other Operating Activities | -1,894 | -437 | -1,006 | -2,954 |
Change in Accounts Receivable | -988 | 287 | 2,850 | -1,020 |
Change in Inventory | -1,133 | -649 | 12 | -2,247 |
Change in Accounts Payable | 466 | 420 | -418 | -676 |
Change in Other Net Operating Assets | -1,011 | -325 | 467 | -1,030 |
Operating Cash Flow | -1,092 | 5,486 | 6,125 | -6,065 |
Operating Cash Flow Growth | - | -10.43% | - | - |
Investing Activities
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
Period Ending | Jul '25 Jul 31, 2025 | Jul '24 Jul 31, 2024 | Jul '23 Jul 31, 2023 | Jul '22 Jul 31, 2022 |
Capital Expenditures | -891 | -841 | -386 | -467 |
Sale of Property, Plant & Equipment | - | -101 | 3 | 306 |
Cash Acquisitions | - | - | - | -1,599 |
Sale (Purchase) of Intangibles | -15 | -31 | -19 | -5 |
Investment in Securities | -64 | -410 | -600 | -721 |
Other Investing Activities | 20 | -7 | -11 | -53 |
Investing Cash Flow | -950 | -1,390 | -1,013 | -2,539 |
Financing Activities
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
Period Ending | Jul '25 Jul 31, 2025 | Jul '24 Jul 31, 2024 | Jul '23 Jul 31, 2023 | Jul '22 Jul 31, 2022 |
Short-Term Debt Issued | - | - | 2,000 | 12,100 |
Long-Term Debt Issued | - | 300 | 2,000 | - |
Total Debt Issued | - | 300 | 4,000 | 12,100 |
Short-Term Debt Repaid | -3,500 | -2,500 | - | - |
Long-Term Debt Repaid | -760 | -1,005 | -760 | -3,243 |
Total Debt Repaid | -4,260 | -3,505 | -760 | -3,243 |
Net Debt Issued (Repaid) | -4,260 | -3,205 | 3,240 | 8,857 |
Issuance of Common Stock | 761 | - | 2 | 5 |
Repurchase of Common Stock | -175 | -999 | -300 | -299 |
Common Dividends Paid | -784 | -626 | -578 | -871 |
Other Financing Activities | -9 | -12 | -23 | -13 |
Financing Cash Flow | -4,467 | -4,842 | 2,341 | 7,679 |
Net Cash Flow
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
Period Ending | Jul '25 Jul 31, 2025 | Jul '24 Jul 31, 2024 | Jul '23 Jul 31, 2023 | Jul '22 Jul 31, 2022 |
Foreign Exchange Rate Adjustments | - | 5 | 5 | -22 |
Miscellaneous Cash Flow Adjustments | - | 2 | 2 | -1 |
Net Cash Flow | -6,509 | -739 | 7,460 | -948 |
Free Cash Flow
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
Period Ending | Jul '25 Jul 31, 2025 | Jul '24 Jul 31, 2024 | Jul '23 Jul 31, 2023 | Jul '22 Jul 31, 2022 |
Free Cash Flow | -1,983 | 4,645 | 5,739 | -6,532 |
Free Cash Flow Growth | - | -19.06% | - | - |
Free Cash Flow Margin | -3.04% | 7.47% | 8.37% | -10.85% |
Free Cash Flow Per Share | -68.99 | 163.32 | 198.74 | -225.13 |
Levered Free Cash Flow | -1,259 | 4,292 | 5,195 | -6,726 |
Unlevered Free Cash Flow | -1,202 | 4,330 | 5,225 | -6,710 |
Additional Metrics
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
Period Ending | Jul '25 Jul 31, 2025 | Jul '24 Jul 31, 2024 | Jul '23 Jul 31, 2023 | Jul '22 Jul 31, 2022 |
Cash Interest Paid | 91 | 62 | 48 | 29 |
Cash Income Tax Paid | 2,247 | 685 | 1,068 | 3,028 |
Change in Working Capital | -2,666 | -267 | 2,911 | -4,973 |